| 1. | | Recruiting | Study of Skin Tumors in Tuberous Sclerosis
Conditions: Hereditary Neoplastic Syndrome; Tuberous Sclerosis |
| 2. | | Recruiting | Microarray Analysis for Human Genetic Disease
Conditions: Breast Neoplasm; Hereditary Neoplastic Syndrome; Melanoma; Ovarian Neoplasm |
| 3. | | Recruiting | Outcomes in Education and Counseling for HNPCC Testing
Conditions: Colonic Neoplasm; Colonic Polyps; Hereditary Neoplastic Syndrome |
| 4. | | Recruiting | Genetic Analysis of Hereditary Prostate Cancer
Conditions: Hereditary Neoplastic Syndrome; Prostatic Neoplasm |
| 5. | | Recruiting | Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm |
| 6. | | Recruiting | Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Conditions: Hemangioblastoma; Hereditary Neoplastic Syndrome; Hippel Lindau Disease; Neoplasm; Renal Cell Carcinoma |
| 7. | | Recruiting | Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
Conditions: Hereditary Neoplastic Syndrome; Neoplasm |
| 8. | | Recruiting | Genetic Polymorphisms in the RASSF1A Gene in Children With Wilms' Tumor
Conditions: recurrent Wilms' tumor and other childhood kidney tumors; stage I Wilms' tumor; stage II Wilms' tumor; stage III Wilms' tumor; stage IV Wilms' tumor; ... |
| 9. | | Recruiting | Pirfenidone in Children and Young Adults with Neurofibromatosis type I and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis 1; Neurofibroma, Plexiform |
| 10. | | Recruiting | Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Condition: neurofibromatosis 1 and 2 (NF1 and NF2) |
| 11. | | Recruiting | Pirfenidone to Treat Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas
Conditions: Neurofibromatosis 1; Plexiform Neurofibroma |
| 12. | | Recruiting | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Conditions: Wilms' Tumor; Wilms' tumor and other childhood kidney tumors |
| 13. | | Recruiting | Genetic Study of Young Patients With Colorectal Cancer
Conditions: Colon Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2); Rectal Cancer |
| 14. | | Recruiting | Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Conditions: Endometrial Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2) |
| 15. | | Recruiting | An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
Condition: Neurofibromatosis 2 |
| 16. | | Recruiting | R115777 to Treat Children with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Conditions: Neurofibroma, Plexiform; Neurofibromatosis Type I |
| 17. | | Recruiting | Temozolomide and O6-Benzylguanine for Treating Childhood Cancers
Conditions: Brain Neoplasm; Embryonal Neoplasm; Ewing's Sarcoma; Germ Cell Neoplasm; Liver Neoplasm; Nephroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma |
| 18. | | Recruiting | NF2 Natural History Consortium
Conditions: Schwannoma, Vestibular; Neurofibromatosis 2; Meningioma |
| 19. | | Recruiting | Studies of Inherited Diseases of Metabolism
Conditions: Hypercalcemia; Hyperparathyroidism; Multiple Endocrine Neoplasia |
